News Releases


Immunother Limited Company Announces Treatment For Inflammatory Syndrome resulting from COVID-19 Infection

Inflammatory Syndrome is an extremely rare and serious complication of COVID-19 infection...

Merger between Immunother and Biogragen

Last year was somewhat of a down year for M&A volume in the biotech industry...

Immunother Limited Company Announces its Participation to IUIS 2019

We are honored to announce the participation of Immunother Ltd. at the world’s leading conference in the field of immunology, IUIS 2019 will offer a uniq...

Immunother Limited Company Completes Private Equity Financing

Immunother Limited Company (ISIN: CN1000207834) has completed a financing in partnership with one of the largest wealth management firms in Shenzhen. “We are delighted with this development, as it is a majo..

Immunother Limited Company Reports Filing of New Intellectual Property

Immunother Limited Company, a preclinical stage biotech company focused on novel treatments to prevent and treat autoimmune conditions and cancer, files patent for HIV and organ transplantation technolog..